With 19.6% CAGR, Nuclear Medicine Market Size to Surpass Around USD 19.47 Billion by 2028 - GlobeNewswire

1 year ago 34

According to Fortune Business Insights, Nuclear Medicine Market to Reach USD 19.47 Billion by 2028, to Witness Rapid Growth connected Account of Adoption of PET Diagnostic Tool arsenic Therapeutic

| Source: Fortune Business Insights


Pune, India, Nov. 03, 2022 (GLOBE NEWSWIRE) -- The nuclear medicine market size was USD 5.04 cardinal successful 2020. The marketplace is studious to turn from USD 5.57 cardinal successful 2021 to USD 19.47 cardinal by 2028 astatine a CAGR of 19.6% during the 2021-2028 period. This study is provided by Fortune Business Insights™, successful its report, titled, “Global Nuclear Medicine, 2021-2028.”

Nuclear medicine is simply a benignant of aesculapian imaging that uses radioactive materials to make pictures of assemblage tissues. These pictures are utilized to diagnose and dainty diseases. The atomic medicine marketplace is segmented based connected applications, product, and geography. The applications conception is further divided into imaging and therapy.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nuclear-medicine-radiopharmaceuticals-market-101812

Industry Development

March 2021: Bracco Diagnostics Inc. declared a collaboration with CardioNavix, LLC to heighten diligent entree to cardiac PET imaging. This caller program, the Bracco Mobile Isotope Service, volition empower much diligent attraction sites to supply cardiac PET imaging.

Report Scope

Report CoverageDetails
Forecast Period2021 to 2028
Forecast Period 2021 to 2028 CAGR19.6%
2028 Value ProjectionUSD 19.47 Billion
Base Year2020
Market Size successful 2021USD 5.57  Billion
Historical Data for2017 to 2019
No. of Pages169

Report Coverage

Our reports are conducted with an exhaustive introspection method that chiefly focuses connected delivering close material. Our scholars person applied a information navigation method that further immunodeficiency america to connection reliable predictions and analyse the atomic medicine America dynamics precisely. Further, our analysts person gained admittance to assorted planetary arsenic good arsenic locally sponsored registers for providing the up-to-date worldly truthful that the stakeholders and concern professionals put lone successful operative zones.

Competitive Landscape

Partnerships Commenced by Key Companies to Promote Market Growth

The dominating players successful the marketplace continually basal for resourceful strategies to promote their marque worth and besides beforehand the planetary marketplace maturation of the merchandise with facing slightest imaginable obstacles. One specified susceptible strategy is gaining competitory companies and truthful fortifying a nett for some the progressive companies.

To get to cognize much astir the short-term and semipermanent interaction of COVID-19 connected this market, delight visit: https://www.fortunebusinessinsights.com/industry-reports/nuclear-medicine-radiopharmaceuticals-market-101812

Driving Factors

Technological Progressions successful Nuclear Imaging Modalities to Boost Market

One of the cardinal aspects for the atomic medicine marketplace maturation is the augmented consciousness concerning the imaginable power of superior and timely diagnosis and the corresponding affirmative sway successful the absorption and attraction of prolonged disorders. Developments successful atomic imaging technology, particularly PET/PET-CT, person helped successful the hold of applications of this modality beyond oncology to cardiology, neurology, and recognition of infections.

There has been a important summation successful the measurement of the PET and SPECT procedures owed to these technological advancements. For instance, different improvements specified arsenic the improvement of cadmium zinc telluride (CZT)-based detectors, which helps successful the simultaneous viewing of physiological and anatomical structures, is expected to thrust the adoption of SPECT-CT systems.

Segmentation

On the ground of the type, the Nuclear Medicine is categorized into diagnostic and therapeutic radiopharmaceuticals. The diagnostic radiopharmaceuticals conception is estimated to clasp the ascendant stock of the planetary marketplace successful 2020.

In presumption of application, the marketplace America is classified into neurology, cardiology, oncology, and others.

By the end-user, the marketplace is divided into hospitals & clinics, diagnostic centers, and others.

Geographically, the marketplace is branched into North America, Europe, Asia Pacific, and the Rest of the World.

Segments-

SegmentationBy Type
  • Diagnostic Radiopharmaceuticals
    • PET Radiopharmaceuticals
      • FDG-PET/18F
      • 68Ga
      • 68Cu
      • 11C
      • Others
    • SPECT Radiopharmaceuticals
      • Technetium-99m
      • Iodine-123
      • Xenon-133
      • Thallium-201
      • Others
  • Therapeutic Radiopharmaceuticals
By Application
  • Neurology
  • Cardiology
  • Oncology
  • Others
By Geography
  • North America (U.S. and Canada)
  • Europe (Germany, U.K., France, Italy, Spain, and Rest of Europe)
  • Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific)
  • Rest of the World

Quick Buy - Nuclear Medicine Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101812

Regional Insights

North America to Lead Backed by Increased Usage of Therapeutic Radiopharmaceuticals

North America created a gross of USD 2.57 cardinal successful 2020 and is projected to proceed its dominance during the forecast period. The punctual adoption of operative atomic imaging technologies pooled with the rising utilization of technologically dependable and proficient therapeutic radiopharmaceuticals crossed the portion are anticipated to substance Nuclear Medicine marketplace growth.

Europe is estimated to clasp the second-highest atomic medicine marketplace America stock owed to the adoption of precocious radiopharmaceuticals and existent merchandise unveilings by salient players.

Asia Pacific is projected to grow astatine a important CAGR during the forecast period.

COVID-19 Impact

COVID-19 Pandemic Hindered Market Revenue Owing to Decreasing Diagnosis Processes

The COVID-19 pandemic adversely influenced the marketplace successful 2020. The concerns specified arsenic scarcity of workforce & staff, the menace of transmission of COVID-19, and the deterioration successful the imaging processes specified arsenic PET-CT SPECT procedures posed a trial for the marketplace maturation successful 2020. The diminution successful the procedures tin beryllium accredited to the interruption successful proviso chains, logistical challenges, and adoption of information measures, which is hard to support by centers.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/nuclear-medicine-radiopharmaceuticals-market-101812

List of Key Players Covered successful the Report

  • Lantheus Medical Imaging, Inc. (U.S.)
  • Cardinal Health (U.S.)
  • Norgine B.V. (Netherlands)
  • Nordion (Canada) Inc. (Canada)
  • Bayer AG (Germany)
  • Curium (France)
  • Advanced Accelerator Applications (Novartis AG) (France)
  • Bracco Diagnostic Inc. (U.S.)
  • Jubilant Pharmova Limited (India)
  • GE Healthcare (General Electric Company) (U.S.)

Some large points from Table of Content:

  • Introduction
    • Market Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
    • Market Trends
  • Key Insights
    • Installed Base of PET/PET-CT Scanners – For Key Countries, 2015 and 2019
    • Installed Base of Gamma Cameras – For Key Countries, 2019
    • PET/PET-CT Procedure Volume –for Key Countries, 2019
    • Reimbursement Scenario- For Key Countries
    • New Product Launches
    • Key Industry Developments
    • Pipeline Analysis
    • Impact of COVID-19 connected the Market
  • Global Nuclear Medicine Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      •  Diagnostics
        •  PET Radiopharmaceuticals
          •  FDG-PET/18F
          •  68Ga
          •  68Cu
          •  11C
          •  Others
        •  SPECT Radiopharmaceuticals
          •  Technetium-99m
          •  Iodine-123
          •  Xenon-133
          •  Thallium-201
          •  Others
      •  Therapeutics
    • Market Analysis, Insights and Forecast – By Application
      •  Neurology
      •  Cardiology
      •  Oncology
      •  Others
    • Market Analysis, Insights and Forecast – By End-user
      •  Hospitals & Clinics
      •  Diagnostic Centers
      •  Others
    • Market Analysis, Insights and Forecast – By Region
      •  North America
      •  Europe
      •  Asia Pacific
      •  Rest of the World
  • North America Nuclear Medicine Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      •  Diagnostics
        •  PET Radiopharmaceuticals
          •  FDG-PET/18F
          •  68Ga
          •  68Cu
          •  11C
          •  Others
        •  SPECT Radiopharmaceuticals
          •  Technetium-99m
          •  Iodine-123
          •  Xenon-133
          •  Thallium-201
          •  Others
      •  Therapeutics
    • Market Analysis, Insights and Forecast – By Application
      •  Neurology
      •  Cardiology
      •  Oncology
      •  Others
    • Market Analysis, Insights and Forecast – By End-user
      •  Hospitals & Clinics
      •  Diagnostic Centers
      •  Others
    • Market Analysis, Insights and Forecast – By Country
      •  U.S.
      •  Canada
  • Europe Nuclear Medicine Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      •  Diagnostics
        •  PET Radiopharmaceuticals
          •  FDG-PET/18F
          •  68Ga
          •  68Cu
          •  11C
          •  Others
        •  SPECT Radiopharmaceuticals
          •  Technetium-99m
          •  Iodine-123
          •  Xenon-133
          •  Thallium-201
          •  Others
      •  Therapeutics
    • Market Analysis, Insights and Forecast – By Application
      •  Neurology
      •  Cardiology
      •  Oncology
      •  Others
    • Market Analysis, Insights and Forecast – By End-user
      •  Hospitals & Clinics
      •  Diagnostic Centers
      •  Others
    • Market Analysis, Insights and Forecast – By Country/ Sub-region
      •  U.K.
      •  Germany
      •  France
      •  Spain
      •  Italy
      •  Scandinavia
      •  Rest of Europe

Continued...

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/nuclear-medicine-radiopharmaceuticals-market-101812

About Us:

Fortune Business Insights™ offers adept firm investigation and close data, helping organizations of each sizes marque timely decisions. We tailor innovative solutions for our clients, assisting them to code challenges chiseled to their businesses. Our extremity is to empower our clients with holistic marketplace intelligence, giving a granular overview of the marketplace they are operating in.

Our reports incorporate a unsocial premix of tangible insights and qualitative investigation to assistance companies execute sustainable growth. Our squad of experienced analysts and consultants usage industry-leading probe tools and techniques to compile broad marketplace studies, interspersed with applicable data.

At Fortune Business Insights™ we purpose astatine highlighting the astir lucrative maturation opportunities for our clients. We, therefore, connection recommendations, making it easier for them to navigate done technological and market-related changes. Our consulting services are designed to assistance organizations place hidden opportunities and recognize prevailing competitory challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Read Entire Article